| scholarly article | Q13442814 |
| P50 | author | Chaitanya Tellapragada | Q57321278 |
| Chiranjay Mukhopadhyay | Q84080308 | ||
| P2093 | author name string | Asha Kamath | |
| Tushar Shaw | |||
| Vandana Kalwaje Eshwara | |||
| P2860 | cites work | Melioidosis in South Asia (India, Nepal, Pakistan, Bhutan and Afghanistan) | Q57145180 |
| Emergence of Burkholderia pseudomallei and pandrug-resistant non-fermenters from southern Karnataka, India | Q58725729 | ||
| The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis | Q21131589 | ||
| Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis | Q26782032 | ||
| Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, Australia | Q33597011 | ||
| The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study | Q33769912 | ||
| Risk factors for melioidosis and bacteremic melioidosis | Q33873235 | ||
| A study on the prevalence of type 2 diabetes in coastal Karnataka | Q33885815 | ||
| The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide | Q34123963 | ||
| Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei | Q34243707 | ||
| Association of melioidosis incidence with rainfall and humidity, Singapore, 2003-2012. | Q34843633 | ||
| Survey of innate immune responses to Burkholderia pseudomallei in human blood identifies a central role for lipopolysaccharide | Q35058621 | ||
| Variable virulence factors in Burkholderia pseudomallei (melioidosis) associated with human disease | Q35117710 | ||
| What drives the occurrence of the melioidosis bacterium Burkholderia pseudomallei in domestic gardens? | Q35585068 | ||
| Unravelling the Molecular Epidemiology and Genetic Diversity among Burkholderia pseudomallei Isolates from South India Using Multi-Locus Sequence Typing | Q36228171 | ||
| Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling | Q36357954 | ||
| Global and regional dissemination and evolution of Burkholderia pseudomallei | Q37634091 | ||
| Clinical presentation and medical management of melioidosis in children: a 24-year prospective study in the Northern Territory of Australia and review of the literature | Q38250307 | ||
| THE CONTRIBUTION OF SOIL PHYSICOCHEMICAL PROPERTIES TO THE PRESENCE AND GENETIC DIVERSITY OF BURKHOLDERIA PSEUDOMALLEI. | Q38948569 | ||
| Melioidosis: refining management of a tropical time bomb. | Q39005336 | ||
| Melioidosis presenting as genitourinary infection in two men with diabetes. | Q39563130 | ||
| Improved detection of Burkholderia pseudomallei from non-blood clinical specimens using enrichment culture and PCR: narrowing diagnostic gap in resource-constrained settings. | Q40199316 | ||
| The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence | Q44760968 | ||
| Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal India. | Q46405247 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | melioidosis | Q963944 |
| P304 | page(s) | e0007312 | |
| P577 | publication date | 2019-05-15 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Implications of environmental and pathogen-specific determinants on clinical presentations and disease outcome in melioidosis patients | |
| P478 | volume | 13 |
| Q100416042 | Myanmar Burkholderia pseudomallei strains are genetically diverse and originate from Asia with phylogenetic evidence of reintroductions from neighbouring countries | cites work | P2860 |
Search more.